ProfMichael O'Reilly

Associate Professor

Department of Medicine

  • Associate Professor
    Department of Medicine

RESEARCH OVERVIEW

Androgen excess; polycystic ovary syndrome; Reproductive Endocrinology; adrenal tumours

GRANTS

  • FUNDED PROJECT
    ICAT-2 Funding - Lauren Madden Doyle
    National University of Ireland, Galway /NUIG13 Jul 2026 - 12 Jul 2029
  • FUNDED PROJECT
    ICAT-2 Funding - Lauren Madden Doyle
    Health Research Board / HRB13 Jul 2026 - 12 Jul 2029
  • FUNDED PROJECT
    Steroid metabolomics as a tool to predict progression to endometrial hyperplasia and carcinoma in women with polycystic ovary syndrome
    Enterprise Ireland23 Apr 2026 - 22 Apr 2028
  • FUNDED PROJECT
    The impact of weight loss induced by bariatric surgery on mineralocorticoid metabolism in men and women living with obesity
    Irish Endocrine Society31 Oct 2025 - 31 Oct 2028
  • FUNDED PROJECT
    A multi-site, open-label, sequential-group, multiple-dose trial to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of Lu AG13909 in participants with congenital adrenal hyperplasia
    Industry - Sponsored Clinical Trial – Economic Activity17 Sep 2025 - 30 Jun 2027
  • FUNDED PROJECT
    BAR11-oxy: The impact of weight loss induced by Bariatric Surgery on metabolism of classic and 11-oxygenated Androgens in men and women with obesity
    Society for Endocrinology18 Jun 2025 - 31 Dec 2026
  • FUNDED PROJECT
    Stipend increase for non state-funded PhD scholars
    RCSI1 Jan 2024 - 30 Sep 2029
  • FUNDED PROJECT
    A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classic Congenital Adrenal Hyperplasia
    Industry24 Aug 2023 - 30 Nov 2027
  • FUNDED PROJECT
    A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal Hyperplasia
    Industry24 Aug 2023 - 30 Nov 2027
  • FUNDED PROJECT
    PRE-receptor activation and Metabolic Impact of 11-oXygenated androgens in polycystic ovary syndrome
    Enterprise Ireland20 Mar 2023 - 19 Mar 2025
  • FUNDED PROJECT
    Development of clinical and research capabilities, infrastructures and programmes.
    Industry - Cash1 Jan 2023 - 1 Aug 2024
  • FUNDED PROJECT
    Tip of the iceberg: highlighting the long term health consequences of polycystic ovary syndrome
    Health Research Board / HRB5 Dec 2022 - 4 Dec 2023
  • FUNDED PROJECT
    Utilising a 3d bioprinting model to dissect the impact of androgen excess on skeletal muscle energy metabolism in women with polycystic ovary syndrome
    RCSI30 Sep 2022 - 29 Sep 2024
  • FUNDED PROJECT
    Exploring the relationship between androgen metabolism, metabolic disease and body mass index in men
    RCSI11 Jul 2022 - 30 Sep 2025
    People funded by this grant:
    • Brian O
  • FUNDED PROJECT
    ICAT Fellowship (Year 2-4) - Leanne Cussen
    Wellcome Trust11 Jul 2022 - 10 Nov 2025
  • FUNDED PROJECT
    ICAT Year 1 Fellowship - Leanne Cussen
    Wellcome Trust12 Jul 2021 - 11 Jul 2022
  • FUNDED PROJECT
    Linking 11-oxygenated androgens, skeletal muscle glucose metabolism and diabetes risk in polycystic ovary syndrome
    Health Research Board / HRB1 Oct 2020 - 30 Sep 2024